Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML)

Leukemia. 2001 May;15(5):855-6. doi: 10.1038/sj.leu.2402112.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytarabine / metabolism
  • Cytarabine / therapeutic use
  • Deoxycytidine Kinase / genetics*
  • Drug Resistance, Neoplasm
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / enzymology
  • Leukemia, Myeloid, Acute / genetics*
  • Mutation*
  • Recurrence

Substances

  • Cytarabine
  • Deoxycytidine Kinase